New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:21 EDTSQNM, FLDM, PKI, DDXS, WAT, PACB, AFFXMaxim recommends life science tools, diagnostics ahead of earnings
Maxim expects 2014 to be a "great year" for life science tools and diagnostics stocks and recommends buying Affymetrix (AFFX), diaDexus (DDXS), Fluidigm (FLDM), Pacific Biosciences (PACB), PerkinElmer (PKI), Sequenom (SQNM) and Waters (WAT) ahead of the Q4 results. Maxim has a preference for Pacific Biosciences, PerkinElmer and Waters. The firm raised its price target for Fluidigm to $52 from $42 and for Pacific Biosciences to $9 from $8.
News For AFFX;DDXS;FLDM;PACB;PKI;SQNM;WAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
11:36 EDTFLDMFluidigm management to meet with Piper Jaffray
Subscribe for More Information
06:06 EDTAFFXAffymetrix announces Chairman and Founder Stephen Fodor to retire from board
Affymetrix announced that Founder and Chairman, Stephen Fodor will retire from the company’s board effective January 30, 2015. The board elected Jami Nachtsheim as Chairwoman of the company’s board, succeeding Fodor. Nachtsheim has served as a director of the company since 2010 and the company’s lead independent director since 2013.
January 29, 2015
16:22 EDTPKIPerkinElmer sees FY15 EPS $2.58-$2.64, consensus $2.64
Subscribe for More Information
16:22 EDTPKIPerkinElmer reports Q4 EPS 85c, consensus 78c
Subscribe for More Information
15:37 EDTPKINotable companies reporting after market close
Subscribe for More Information
January 26, 2015
17:26 EDTWATWaters sees Q1 EPS 95c-$1.05, consensus $1.07
Subscribe for More Information
17:25 EDTWATWaters sees FY15 EPS $5.55-$5.80, consensus $5.84
Sees stable increases in revenue during FY15. Sees FY15 market conditions better than in FY14. Guidance provided during Q4 earnings conference call.
16:02 EDTWATWaters reports Q4 EPS $1.99, consensus $1.89
Subscribe for More Information
January 23, 2015
15:46 EDTPACB, FLDM, SQNMPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 22, 2015
07:04 EDTSQNMSequenom and Cypher Genomics sign prenatal test development agreement
Subscribe for More Information
January 21, 2015
10:01 EDTAFFXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:21 EDTAFFXAffymetrix downgraded to Neutral from Outperform at RW Baird
Baird downgraded Affymetrix to Neutral from Outperform citing reduced risk/reward. Baird maintains its $11 price target on Affymetrix shares.
January 20, 2015
13:45 EDTSQNMIllumina rises as genomics project seen being announced in State of the Union
Subscribe for More Information
07:53 EDTFLDMFluidigm upgraded to Outperform at Cowen
Subscribe for More Information
06:36 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use